GlassScriptPhysician profile
Romel C Castro
NPI 1972040756
$1,799.66
in general payments reported to CMS, 2019-2025
7 companies · $557 in 2025
The $557 reported for 2025 was more than what 97% of Nurse Anesthetist, Certified Registered providers received nationally (typical 2025 total: $45.72).
See the full distribution for Nurse Anesthetist, Certified Registered
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $162 · 2022: $294 · 2023: $315 · 2024: $470 · 2025: $557.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,343.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,342.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $685.36 | 2021-2024 | Vanta Adaptivestim, Intellis Adaptivestim, Synchromedii |
| Abbvie INC. | $648.36 | 2024-2025 | |
| Abbott Laboratories | $193.93 | 2022-2025 | Proclaim |
| Biotronik Nro, INC. | $113.13 | 2025 | Prospera |
| Baudax Bio INC. | $87.67 | 2021-2022 | |
| Rayner Intraocular Lenses Limited | $51.38 | 2023 | Rayone Aspheric, Omidria, Rayone Emv |
| Painteq LLC | $19.83 | 2023 | Painteq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Romel Castro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.